EXTRA[NOT]ORDINARY Trademark
Serial Number: 98192187 • Registration: 7402053
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 45 - Legal & Security Services
Legal services; security services for the protection of property and individuals
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
September 22, 2023
Registration Date
May 28, 2024
Published for Opposition
March 12, 2024
Goods & Services
Pharmaceutical and veterinary preparations, including pharmaceutical preparations based on antibodies for the treatment of cancer, autoimmune diseases, and inflammatory disorders
Chemical, biochemical, biological, and biotechnological preparations, namely, antibodies and bi- and multispecific antibodies in the nature of monoclonal antibodies for in vitro and in vivo scientific research and development use with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, autoimmune diseases, and inflammatory disorders
Legal services related to the exploitation of patents and licensing of intellectual property in the field of medicine patents
Medical, scientific and biological research, namely, medical and scientific research into antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these
